Is Invokamet XR a Controlled Substance? No

No. Invokamet XR (canagliflozin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and canagliflozin and metformin is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Invokamet XR?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Invokamet XR
Source	What it lists
FDA NDC directory	4 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances list	canagliflozin and metformin is not on the list

Invokamet XR NDC listings

NDC listings for Invokamet XR
NDC	Product	Form	Strength	Labeler	DEA schedule
50458-943	INVOKAMET XR	tablet, film coated, extended release	150 mg/1; 1000 mg/1	Janssen Pharmaceuticals, Inc.	None
50458-942	INVOKAMET XR	tablet, film coated, extended release	150 mg/1; 500 mg/1	Janssen Pharmaceuticals, Inc.	None
50458-941	INVOKAMET XR	tablet, film coated, extended release	50 mg/1; 1000 mg/1	Janssen Pharmaceuticals, Inc.	None
50458-940	INVOKAMET XR	tablet, film coated, extended release	50 mg/1; 500 mg/1	Janssen Pharmaceuticals, Inc.	None

Questions

Is Invokamet XR a controlled substance?

No. Invokamet XR (canagliflozin and metformin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and canagliflozin and metformin is not on the DEA controlled substances list.

Is Invokamet XR a narcotic?

No. Invokamet XR (canagliflozin and metformin) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Biguanide and Sodium-Glucose Cotransporter 2 Inhibitor.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.